You have 9 free searches left this month | to do more
Showing 1 - 25 of
2,999 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer
Active, not recruiting
  • Cervical Cancer
  • Leuven, Belgium
    UZLeuven
2021-01-26
Jan 26, 2021
M
Lurbinectedin + Doxorubicin In Leiomyosarcoma
Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
2021-10-18
Oct 18, 2021
E
A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma
Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • Doxorubicin
  • +2 more
  • (no location specified)
2021-10-08
Oct 8, 2021
C
APX005M and Doxorubicin in Advanced Sarcoma
Recruiting
  • Soft Tissue Sarcoma
  • New York, New York
    Columbia University Medical Center
2021-11-12
Nov 12, 2021
S
Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma
Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
2021-11-15
Nov 15, 2021
N
A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma
Not yet recruiting
  • Metastatic Soft-tissue Sarcoma
  • (no location specified)
2021-10-20
Oct 20, 2021
M
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-04-08
Apr 8, 2021
N
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, (DURVA+ Study)
Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Bethesda, Maryland
    National Cancer Institute Developmental Therapeutics Clinic
2021-09-09
Sep 9, 2021
U
Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas - 2021
Completed
  • Soft Tissue Sarcoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-11-26
Nov 26, 2021
G
Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma - 2021
Completed
  • Uterine or Soft Tissue Leiomyosarcoma
  • Villejuif, Val De Marne, France
    Gustave Roussy
2021-12-10
Dec 10, 2021
M
Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma
Active, not recruiting
  • Soft Tissue Sarcoma, Adult
  • Soft Tissue Sarcoma, Child
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-12-14
Dec 14, 2021
N
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
Suspended
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +25 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
2021-11-19
Nov 19, 2021
A
Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma
Active, not recruiting
  • Metastatic Adult Soft Tissue Sarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Durvalumab and Tremelimumab
  • Doxorubicin
  • Hannover, Germany
    Medizinische Hochschule Hannover
2021-06-01
Jun 1, 2021
M
Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Doxorubicin
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-07-14
Jul 14, 2021
S
Biomarkers of Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
Recruiting
  • Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
  • Blood sampling
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
2021-12-21
Dec 21, 2021
R
The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor - 2020
Completed
  • Doxorubicin Adverse Reaction
  • +2 more
    • Chicago, Illinois
    • +1 more
    2021-04-23
    Apr 23, 2021
    R
    A Registry Study in Lymphoma Patients Treated With Liposomal Doxorubicin
    Recruiting
    • Lymphoma
    • liposomal doxorubicin
    • Shanghai, Shanghai, China
      Ruijin Hospital
    2021-03-13
    Mar 13, 2021
    M
    Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Recruiting
    • Recurrent Fallopian Tube Carcinoma
    • +2 more
    • Bevacizumab
    • +4 more
    • Phoenix, Arizona
    • +2 more
    2021-04-06
    Apr 6, 2021
    U
    PanDox: Targeted Doxorubicin in Pancreatic Tumours
    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +3 more
    • Focused Ultrasound
    • +2 more
    • Oxford, United Kingdom
      Oxford University Hospitals NHS Trust
    2021-08-23
    Aug 23, 2021
    P
    A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma
    Recruiting
    • Soft Tissue Sarcoma
    • Onfekafusp alfa
    • Doxorubicin
    • Bad Saarow, Germany
    • +1 more
    2020-11-25
    Nov 25, 2020
    U
    Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients
    Recruiting
    • Advanced Soft-tissue Sarcoma
    • Metastatic Soft-tissue Sarcoma
    • Toulouse, France
      Institut Claudius Reagaud-IUCT Oncopôle
    2021-09-27
    Sep 27, 2021
    A
    AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours
    Active, not recruiting
    • Solid Tumors
    • Milano, Italy
    • +2 more
    2021-11-17
    Nov 17, 2021
    Y
    Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
    Recruiting
    • Stage III Adult Soft Tissue Sarcoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    2021-02-18
    Feb 18, 2021
    N
    Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
    Recruiting
    • Kaposi Sarcoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-12-14
    Dec 14, 2021
    U
    Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
    Recruiting
    • Metastatic Soft Tissue Sarcoma
    • Advanced Soft Tissue Sarcoma
    • doxorubicin with AGEN1884 and AGEN2034
    • Aurora, Colorado
      University of Colorado Hospital
    2021-03-05
    Mar 5, 2021